Thierry Burnouf: Platelet-Derived Therapies Show Promise for Restoring Neuronal Mitochondrial Function
Thierry Burnouf, Professor of Biomedical Engineering at Taipei Medical University, has shared a post on LinkedIn:
“Our new preprint is now available on bioRxiv: ‘Human Platelet-Derived Lysates and Extracellular Vesicles Restore Mitochondrial Function and Redox Balance in Neuronal Models’
This work, led by KIRTI GUPTA with contributions from Liling Delila, David Blum, Anup Pandith, and Thierry Burnouf, shows how platelet-derived formulations can restore mitochondrial activity and rebalance redox stress in models of neurodegeneration.
Mitochondrial dysfunction and oxidative stress are common hallmarks of neurodegenerative diseases. We show that two clinically compliant platelet-derived products, a purified platelet lysate (HPPL), and a population of platelet extracellular vesicles (PEVs) rescue mitochondrial activity, reduce oxidative stress, and improve neuronal survival in both cell models and zebrafish embryos.
Data confirm that outdated clinical-grade platelet concentrates can provide a safe, scalable, and locally accessible resource for developing biotherapies, even in countries with limited infrastructure for advanced biologics manufacturing.”
Title: Human Platelet-derived Lysates and Extracellular Vesicles Restore Mitochondrial Function and Redox Balance in Neuronal Models
Authors: Kirti Gupta, Liling Delila, David Blum, Anup Pandith, Thierry Burnouf
Read the full article here.
More recent insights on Hemostasis Today.
-
Sep 29, 2025, 12:54Microfluidic Technology Uncovers Ongoing TTP Disease Activity
-
Sep 29, 2025, 12:43Advancing Thrombosis Research: MRI-Based Methodology for Studying Thrombus Resolution
-
Sep 29, 2025, 05:58Samwel Mikaye on Understanding, Diagnosing, and Managing Deep Venous Thrombosis (DVT)
-
Sep 28, 2025, 14:08Mary Cushman: Dr Warkentin Is a Giant in Hematology
-
Sep 28, 2025, 13:31Michael Makris Highlights Vaccine Misinformation and Its Risks
-
Sep 29, 2025, 12:33Allison Wheeler: Some Days I Love Science a Little Bit More
-
Sep 29, 2025, 06:23Yudi Hardianto and Colleagues Give a Review on Stroke Rehabilitation in LMICs
-
Sep 29, 2025, 04:42Wolfgang Miesbach on the Bi8 Study: A Novel FVIII-Mimetic Antibody Gene Therapy for Haemophilia A
-
Sep 29, 2025, 04:16Salvador Payán Pernía on Equity Challenges in Access to Gene Therapy for Hemoglobinopathies
-
Sep 29, 2025, 04:02Nicolas Gendron: A Very Nice Demonstration by The Authors - Coffee is Associated with Reduced Risk of VTE
-
Sep 29, 2025, 05:06Sue Bacon on the Importance of Addressing Hospital-Acquired DVT and PE
-
Sep 24, 2025, 11:06Wolfgang Miesbach Reports Promising Results for New Subcutaneous von Willebrand Disease Therapy VGA039
-
Sep 23, 2025, 06:40Richard Buka: CSL Behring Have Announced a Collaboration with Dutch Biotech, VarmX
-
Sep 22, 2025, 07:10Aspirin Beyond the Heart․ Targeting PI3K-Altered Colorectal Cancer
-
Sep 22, 2025, 06:04ClearPlasma: A New Filter Technology to Enhance Clot Stability in Donated Plasma
-
Sep 29, 2025, 07:02Kambua Manundu: We Walked to Protest the Countless Lives of Women We Have Lost to Post Partum Hemorrhage
-
Sep 29, 2025, 06:41Ouma Oluga Unveiled Plans to Make Sickle Cell Screening Mandatory in Kenya at 80th UN General Assembly
-
Sep 29, 2025, 04:51Nathan Connell on Breakthrough Gene Therapy Advancing Care for People with Hemophilia
-
Sep 29, 2025, 04:28Emmeran Hauser: Fantastic to See First Results of Our Work in Europe
-
Sep 28, 2025, 10:33Côme Bommier: Burnout Is Common Among Hematology Professionals